D.A. Davidson & CO. Has $2.82 Million Stock Position in Synopsys, Inc. $SNPS

D.A. Davidson & CO. boosted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 30.8% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 5,715 shares of the semiconductor company’s stock after buying an additional 1,346 shares during the quarter. D.A. Davidson & CO.’s holdings in Synopsys were worth $2,820,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the stock. Norges Bank bought a new stake in shares of Synopsys during the 2nd quarter worth approximately $647,964,000. Ameriprise Financial Inc. increased its holdings in Synopsys by 29.1% during the second quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock worth $1,333,095,000 after buying an additional 585,494 shares during the last quarter. Ninety One UK Ltd acquired a new position in Synopsys during the third quarter worth $249,851,000. Aspex Management HK Ltd raised its position in Synopsys by 106.0% during the second quarter. Aspex Management HK Ltd now owns 645,895 shares of the semiconductor company’s stock worth $331,137,000 after acquiring an additional 332,364 shares in the last quarter. Finally, Vanguard Group Inc. lifted its stake in Synopsys by 1.6% in the second quarter. Vanguard Group Inc. now owns 15,060,784 shares of the semiconductor company’s stock valued at $7,721,363,000 after acquiring an additional 231,014 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors.

Synopsys Stock Performance

Shares of NASDAQ SNPS opened at $514.49 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. The firm has a market cap of $98.43 billion, a price-to-earnings ratio of 64.39, a P/E/G ratio of 4.32 and a beta of 1.12. The stock’s fifty day moving average price is $443.64 and its two-hundred day moving average price is $504.01. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The company had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.25 billion. During the same quarter in the previous year, the business posted $3.40 earnings per share. Synopsys’s quarterly revenue was up 37.8% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, equities analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current year.

Insider Activity at Synopsys

In other news, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Janet Lee sold 250 shares of the business’s stock in a transaction that occurred on Wednesday, January 7th. The shares were sold at an average price of $510.00, for a total value of $127,500.00. Following the completion of the sale, the insider owned 12,209 shares of the company’s stock, valued at approximately $6,226,590. This trade represents a 2.01% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.62% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Weiss Ratings restated a “hold (c)” rating on shares of Synopsys in a research note on Wednesday, October 8th. Rosenblatt Securities upgraded Synopsys from a “neutral” rating to a “buy” rating and reduced their price target for the stock from $605.00 to $560.00 in a report on Tuesday, December 9th. BNP Paribas began coverage on Synopsys in a research report on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price target on the stock. Needham & Company LLC upped their price objective on Synopsys from $550.00 to $580.00 and gave the company a “buy” rating in a research note on Thursday, December 11th. Finally, JPMorgan Chase & Co. raised their price objective on Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a research report on Thursday, December 11th. Eleven analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $562.13.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.